Application of 2', 5, 6', 7-tetrahydroxy dihydroflavonol for treating sepsis
A technology of Tetrahydroxydihydroflavonol, sepsis, applied in the field of 2'
Inactive Publication Date: 2010-08-11
THE FIRST AFFILIATED HOSPITAL OF THIRD MILITARY MEDICAL UNIVERSITY OF PLA
View PDF0 Cites 0 Cited by
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
So far, there are no reports of THF and its derivatives and analogs neutralizing LPS and preparing drugs for treating sepsis
Method used
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View moreImage
Smart Image Click on the blue labels to locate them in the text.
Smart ImageViewing Examples
Examples
Experimental program
Comparison scheme
Effect test
Embodiment 1
Embodiment 2
Embodiment 3
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More PUM
Login to View More
Abstract
The invention relates to the usage of a 2',5',6',7'-tetrahydroxyflavanonol and the derivative in treating pyohemia, belonging to flavanonol compound THF, which is extracted and separated from baikal skullcap root of Chinese herbal medicine. Through experiment showing, the THF has the advantages that: the THF has direct neutralization effect and reveals better dose effect relationship; the THF also reveals better dose effect relationship upon inhibition of RAW 264.7 cells activation LPS stimulation; the THF can lower LPS level in blood of LPS blood symptom model animal in vivo; the THF also has obvious protection effect upon bacterial sepsis model mouse caused by heat-inactivation escherichia coli with lethal dose; the THF has good application prospect under the condition of lacking effective means treating pyohemia in prior study.
Description
technical field The invention relates to the use of 2', 5, 6', 7-tetrahydroxy dihydroflavonol and derivatives thereof for treating sepsis. Background technique Sepsis is an infectious agent-mediated systemic inflammatory response syndrome (systemic inflammatory response syndrome, SIRS), which is a common complication in patients with burns, trauma and infectious diseases. Epidemiological data show that there are more than 18 million sepsis cases worldwide every year, and the number of patients is increasing at a rate of 1.0% every year. Severe sepsis and septic shock are the leading causes of death in intensive care units (ICU), with a mortality rate as high as 50%-60%. LPS is the main component of the outer membrane of G-bacteria, and is an important pathogen-associated molecular pattern (pathogen-associated molecular patterns, PAMPs) mediating bacterial sepsis. After LPS enters the body, it first binds to lipopolysaccharide-binding protein (LBP). Under the action of LBP...
Claims
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More Application Information
Patent Timeline
Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): A61K31/352A61P17/02A61P29/00
CPCY02A50/30
Inventor 郑江伏建峰周红郑新川刘鑫曹红卫王宁鲁永玲
Owner THE FIRST AFFILIATED HOSPITAL OF THIRD MILITARY MEDICAL UNIVERSITY OF PLA
Who we serve
- R&D Engineer
- R&D Manager
- IP Professional
Why Patsnap Eureka
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com